Karo Pharma acquires Sylphar International NV for EUR 290m and intends to carry out a rights issue of approximately EUR 200-250m
Karo Pharma Aktiebolag (publ) (the ”Company” or ”Karo”) has today entered into an agreement to acquire all of the shares in Sylphar International NV (“Sylphar”) and, direct and indirect, all of the shares in Pro Teeth Whitening Co Limited (“Pro Teeth Whitening”), Nutravita Limited (“Nutravita”) and Alpha Foods BV (“Alpha Foods”, together the “Sylphar Group”) from Vendis Capital and Robin List, Sylphar’s founder, for EUR 290m (the ”Transaction”). The Transaction is expected to contribute positively to Karo’s market position and further enhance Karo’s strong platform for continued growth,